Ocular Therapeutix Inc (NAS:OCUL)
$ 5.8 -0.2 (-3.33%) Market Cap: 898.36 Mil Enterprise Value: 520.85 Mil PE Ratio: 0 PB Ratio: 2.20 GF Score: 78/100

Ocular Therapeutix Inc at Jefferies Healthcare Conference Transcript

Jun 08, 2023 / 04:30PM GMT
Release Date Price: $7.61 (+2.70%)
Chris Howerton
Jefferies - Analyst

Okay, everybody. Thank you so much for joining us after the lunch session here. My name is Chris Howerton, part of the Jefferies biotechnology research team. Really excited to be here at our conference this year and also to be hosting this fireside chat with you, Antony. So thanks so much for joining us. And this is, of course, Ocular Therapeutix.

Antony Mattesich
Ocular Therapeutix, Inc. - President and CEO

Good to see you again, Chris. Thanks for inviting us.

Chris Howerton
Jefferies - Analyst

Awesome. Well, for those that may be a little bit uninitiated to the name, maybe you could give us a little bit of elevator pitch to get us started.

Antony Mattesich
Ocular Therapeutix, Inc. - President and CEO

The elevator pitch for Ocular Therapeutix is we're building ourselves into a strategic company in ophthalmology with both front and back of the eye assets. We have a commercial business that is profitable and able to take new products

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot